Drug
Minoxidil clinical trials
Also written Rogaine.
- studies test it
- 40
- open now
- 12
- in phase 3
- 8
- first study started
- 2003
Keep track of what changes. Save the Minoxidil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
38 studies that test it; most in 2023 (6); 2 more planned to start later
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 4
- Phase 1
- 6
- Phase 2
- 11
- Phase 3
- 8
- Phase 4
- 4
- No phase
- 10
What it is tested for
Each study’s main condition, where its own words name it.
- Alopecia
- 29
Who runs them
Industry 12 · Other 28
Industrial Farmacéutica Cantabria, S.A. (2) · Galderma R&D (2) · Sohag University (2) · Aneira Pharma, Inc. (2) · Northwestern University (1) · Memorial Sloan Kettering Cancer Center (1) · Tanta University (1) · Samson Clinical Operations Pty Ltd (1)
Often tested with
Tested in the same studies.
Finasteride (3) · Spironolactone (2) · Nitroglycerin (1) · Triamcinolone Acetonide (1) · Clobetasol (1) · Docosahexaenoic Acids (1) · Vitamin D (1) · Hydralazine (1)
Studies
Open first, then newest update. How each study uses Minoxidil is read from its arms, and is right about nine times in ten.
Testing it · 40
- A Study on the Efficacy and Safety of Microneedling for Male Androgenetic AlopeciaNot yet recruitingNot applicableCheng ZhouNCT07758400Written as Minoxidil 5 %
- Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast ReconRecruitingPhase 1Duke UniversityNCT07264790Written as Minoxidil
- JAK2 Expression in Androgenetic Alopecia Before and After Topical MinoxidilRecruitingNot applicableKasr El Aini HospitalNCT07563036Written as Topical Minoxidil 5% Solution
- Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.Not yet recruitingPhase 3Eurofarma Laboratorios S.A.NCT07529977Written as Minoxidil oral solution
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast CancerRecruitingEarly Phase 1Ohio State University Comprehensive Cancer CenterNCT05417308Written as Minoxidil
- Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic AlopeciaNot yet recruitingPhase 3Sheikh Zayed Federal Postgraduate Medical InstituteNCT07273799Written as Minoxidil 5 % Topical Spray
- Low Dose Oral Minoxdil in Androgenic AlopeciaNot yet recruitingNot applicableJinnah Postgraduate Medical CentreNCT07018349Written as 2.5% Oral minoxidil
- Efficacy of Dihydroartemisinin for Treating Female Androgenetic AlopeciaRecruitingEarly Phase 1Shanghai Zhongshan HospitalNCT07012486Written as Oral DHA + Topical minoxidil 5%
- Various Procedural Treatment Options for Androgenetic AlopeciaNot yet recruitingPhase 2Sheikh Zayed Medical CollegeNCT06826001Written as Topical minoxidil
- Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair LossRecruitingPhase 1/2Sohag UniversityNCT06333600Written as Topical minoxidil
- Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian CancerRecruitingPhase 2Loyola UniversityNCT05272462Written as Minoxidil
- Phase I Study of Safety and Pharmacokinetics of Topical Solution in Subjects With Androgenetic AlopeciaNot yet recruitingPhase 1Aneira Pharma, Inc.NCT05864885Written as Minoxidil
- Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic AlopeciaActive, not recruitingPhase 3Industrial Farmacéutica Cantabria, S.A.NCT05888922Written as Minoxidil Tablets
- Exosome Injection Versus Topical Minoxidil for Androgenetic AlopeciaCompletedNot applicableTanta UniversityNCT07776015Written as Topical Minoxidil 5%
- Efficacy & Safety of Minoxidil SL Tablets in Men With AGACompletedPhase 3Samson Clinical Operations Pty LtdNCT06924632Written as Minoxidil
- Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced AlopeciaActive, not recruitingEarly Phase 1Northwestern UniversityNCT03831334Written as oral minoxidil
- Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic AlopeciaCompletedPhase 2Beijing Dayspring Pharmaceutical Technology Co., LtdNCT07076706Written as minoxidil + finasteride
- A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer SurvivorsActive, not recruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT05778825Written as Oral Minoxidil
- Efficacy of Minoxidil in Children With Williams-Beuren SyndromeCompletedPhase 2Hospices Civils de LyonNCT00876200Written as Minoxidil
- N-Acetyl-Cysteine for Treatment of AGA in MenCompletedPhase 4Kafrelsheikh UniversityNCT04209803Written as Minoxidil 5% topically and oral NAC 600 mg
See all 40 studies that test Minoxidil →
Given in every arm · 7 — Minoxidil is usual care beside what is tested
- Minoxidil With or Without Low-Level Red-Light Therapy for Improving Chemotherapy-Induced Alopecia in Breast Cancer PatientsNot yet recruitingPhase 2Ohio State University Comprehensive Cancer CenterNCT07594678Written as Minoxidil
- Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective StudyRecruitingPhase 4Wake Forest University Health SciencesNCT04207931Written as Minoxidil
- Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic AlopeciaRecruitingPhase 2/3Indonesia UniversityNCT05990400Written as Minoxidil
- Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian MenCompletedPhase 3Indonesia UniversityNCT05989165Written as Minoxidil 5% Topical Solution
- Topical Cetirizine in Androgenetic Alopecia in FemalesCompletedPhase 2/3Cairo UniversityNCT04481412Written as Topical minoxidil
- Evaluating the Topical Herbal Solution on the Treatment of Male Pattern Hair Loss and Comparison With Minoxidil 5%CompletedPhase 3Farid MasoudNCT03753113Written as Topical Minoxidil 5%
- A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair LossCompletedPhase 2Merz Pharmaceuticals GmbHNCT01900041Written as Minoxidil 2% only
As the comparator · 23 — what is tested is compared with Minoxidil
- VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic AlopeciaRecruitingNot applicableInstitute of Dermatology, ThailandNCT07536100Written as Topical minoxidil
- The Effect of Nanofat Injection on Androgenetic AlopeciaNot yet recruitingPhase 4Assiut UniversityNCT07518342Written as Minoxidil 5 %
- Topical 2-Deoxy-D-ribose Hydrogel Versus Minoxidil 5% Solution for Androgenetic AlopeciaRecruitingNot applicableKasr El Aini HospitalNCT07502976Written as Topical Minoxidil 5% Solution
- Topical Application of Lactobacillus Reuteri for Androgenetic AlopeciaRecruitingPhase 2Shenzhen People's HospitalNCT07370519Written as 5% Minoxidil
- Androgenic Alopecia TH07 Clinical TrialRecruitingPhase 3Triple Hair IncNCT07435012Written as Minoxidil 5% Topical Solution
- Topical Methotrexate vs Minoxidil for Localized Alopecia AreataNot yet recruitingPhase 4Jinnah Postgraduate Medical CentreNCT07459933Written as Minoxidil 5% Topical Spray
- Efficacy and Safety of Finlândia Hair Lotion Association on Androgenetic AlopeciaRecruitingPhase 3EMSNCT04594018Written as Minoxidil + finasteride
- A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell ExosomesRecruitingPhase 1/2Shenzhen People's HospitalNCT07203599Written as Minoxidil 5% Topical Solution
- Clinical Study of DA-002 and DA-005 As a Treatment for Hair LossNot yet recruitingPhase 3Applied Biology, Inc.NCT06501924Written as Topical minoxidil 5%
- Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic AlopeciaRecruitingNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT06218394Written as 5% minoxidil
- Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic AlopeciaRecruitingNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT06218498Written as 5% Minoxidil
- Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in the Treatment of Androgenic AlopeciaCompletedNot applicableFujian Medical University Union HospitalNCT07373054Written as Topical Minoxidil
- Effects of a Topical Serum Solution on Hair CharacteristicsActive, not recruitingNot applicablePacagen, Inc.NCT07785869Written as Topical Minoxidil 2%
- A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.Active, not recruitingPhase 2PDFE Pharma Innovations FZCONCT07011485Written as Minoxidil 5% Topical Solution
- Clinical Study of Probiotic Treatment for Androgenetic AlopeciaWithdrawnPhase 3Applied Biology, Inc.NCT06484881Written as Topical minoxidil 5%
- A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia AreataCompletedEarly Phase 1Assiut UniversityNCT06527729Written as minoxidil gel
- Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in MenCompletedPhase 1/2Dermaliq Therapeutics, Inc.NCT05636904Written as Minoxidil 5% Topical Solution
- ENERGI-F701 for Female Hair Loss TreatmentCompletedPhase 2Energenesis Biomedical Co., Ltd.NCT03351322Written as Regaine
- Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic AlopeciaStatus unknownPhase 4Assiut UniversityNCT04293822Written as Minoxidil
- A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic AlopeciaCompletedPhase 2Intrepid Therapeutics, Inc.NCT02279823Written as Minoxidil Solution 5%
Showing 20 of 23.
Codes
What other systems call Minoxidil · ClinicalTrials.gg INT007841
- MeSH (NLM) D008914MinoxidilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5965120SH1MINOXIDILConfirmed FDA, NLM, Wikidata
- RxNorm 6984Confirmed FDA, Wikidata
- Wikidata Q424165minoxidilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47623MinoxidilOne source FDA
- DrugBank DB00350One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D008914 | Minoxidil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5965120SH1 | MINOXIDIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6984 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424165 | minoxidil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47623 | Minoxidil | One source FDA |
| DrugBank | DB00350 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.